Intelligence Platform
Patents
Browse 1,742 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9649344
Methods and compositions for in vivo induction of pancreatic beta cell formation
granted patentUS 9649373
Neoseptins: small molecule adjuvants
granted patentUS 9645139
Neuroprotective chemicals and methods for identifying and using same
granted patentUS 9642859
Use of capsazepine and analogs thereof to treat cancer
granted patentUS 9638639
Plasmonic-magnetic bifunctional nanotubes for biological applications
granted patentUS 9631041
PH-sensitive compositions for delivery of beta lapachone and methods of use
granted patentUS 9629877
Human application of engineered chimeric antigen receptor (CAR) T-cells
granted patentUS 9630990
Inhibition of pulmonary fibrosis with nutlin-3A and peptides
granted patentUS 9624211
Anti-cancer compounds
granted patentUS 9624484
Engineered primate L-methioninase for therapeutic purposes
granted patentUS 9616048
Anti-depression compounds
granted patentUS 9616076
Methods for treating viral infections using hydrogen sulfide donors
granted patentUS 9617511
Tissue-specific differentiation matrices and uses thereof
granted patentUS 9618521
Sperm-specific cation channel, Catsper2, and uses therefor
granted patentUS 9611292
Peptide inhibitors of serotonin 5-HT2c receptors:PTEN interaction
granted patentUS 9611266
Compounds and anti-tumor NQO1 substrates
granted patentUS 9605057
Endotrophin neutralization and use thereof
granted patentUS 9598694
Micro-RNAs involved in macular degeneration
granted patentUS 9592238
Anti-ceramide monoclonal antibody 2A2
granted patentUS 9593131
Copper-cysteamine and methods of use
granted patentUS 9585910
Polymers functionalized with ion-specific recognition elements
granted patentUS 9579370
Compositions and methods for enterohemorrhagic Escherichia coli (EHEC)vaccination
granted patentUS 9580690
Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereo
granted patentUS 9574191
Selective inhibition of polyglutamine protein expression
granted